Representative before the EPO

Company dna sagittarius ip
no operation time available
1 office
active in Legal Services

Andrew John Teuten has worked on the following 69 EPO patent applications which have been published in the last five years:

EP11729448

P38 MAP KINASE INHIBITORS

IPC classification:
A61K 31/4155, A61P 11/00, C07D 401/12, C07D 401/14, C07D 405/14, C07D 409/14
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11705985

PROTEIN FORMULATIONS

IPC classification:
A61K 9/00, A61K 39/395, A61K 47/12
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11708813

IMMOBILISED BIOLOGICAL ENTITIES

IPC classification:
A61L 33/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
The patent has been granted
EP10788125

INHIBITORS OF HEMOPOIETIC CELL KINASE (P59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION

IPC classification:
A61K 31/4155, A61K 45/06, A61P 31/16, G01N 33/50
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11751030

SYSTEM AND METHOD FOR COMPRESSED BED GRINDING IN A STIRRED MEDIA MILL

IPC classification:
B02C 17/02, B07B 13/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION WITHDRAWN
EP13166988

Methods and compositions for administration of iron

IPC classification:
A61K 31/715, A61P 7/06
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11183688

1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 MAP kinase inhibitors

IPC classification:
A61K 31/4155, A61K 31/506, C07D 403/12
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION REFUSED
EP12704527

COMBINATION THERAPY FOR CANCER

IPC classification:
A61K 38/45, A61K 48/00, A61P 35/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12864756

BAP1 MUTATIONAL ANALYSIS IN DETERMINING SUSCEPTIBILITY TO, PROGNOSIS OF, AND TREATMENT OF MELANOCYTIC NEOPLASIA

IPC classification:
G01N 33/48, G01N 33/53
Applicant:
Graz University of Medicine (Medizinische Universit├Ąt Graz)
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP11191986

Novel pyrrole compounds

IPC classification:
A61K 31/402, A61K 31/4245, A61K 31/427, A61K 31/4439, A61P 31/04, C07C 211/48, C07D 207/36, C07D 401/04, C07D 401/12, C07D 403/04, C07D 407/04, C07D 413/04, C07D 417/04
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION REFUSED
EP12708138

IMPROVEMENTS TO IMMOBILISED BIOLOGICAL ENTITIES

IPC classification:
A61K 47/48, A61L 27/34, A61L 31/10, A61L 33/00
Applicant:
W.L. Gore & Associates Inc
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12723442

CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHODS FOR THE PREPARATION AND USES THEREOF

IPC classification:
A61K 35/14, A61K 39/00, A61P 37/00, C12N 5/0783
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12741268

NK-1 RECEPTOR ANTAGONISTS FOR TREATING CORNEAL NEOVASCULARISATION

IPC classification:
A61K 31/445, A61K 31/5377, A61K 31/675, A61K 45/06, A61P 27/02
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12772383

1-PYRAZOLYL-3- (4- ( (2 -ANILINOPYRIMIDIN- 4 - YL) OXY) NAPTHTHALEN- 1 - YL) UREAS AS P38 MAP KINASE INHIBITORS

IPC classification:
A61K 31/4155, A61K 31/506, C07D 403/12, C07D 491/10
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12772382

L-PYRAZOLYL-3- (4- ( (2 -ANILINOPYRIMIDIN- 4 - YL) OXY) NAPTHTHALEN- 1 - YL) UREAS AS P3I MAP KINASE INHIBITORS

IPC classification:
A61K 31/4155, A61K 31/506, C07D 403/12
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12839144

DIMERIC BACTERIOPHAGE LYSINS

IPC classification:
C12N 7/00
Applicant:
The Rockefeller University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP12884742

NOVEL COMPOUND FOR IMAGING TAU PROTEIN ACCUMULATED IN THE BRAIN

IPC classification:
A61K 49/00, A61K 51/00, A61P 25/28, C07D 277/64, C07D 401/06, C07D 405/06, C07D 417/06, C07D 417/14
Agent:
Andrew John Teuten, Sagittarius IP
Status:
PATENT GRANTED
EP11706318

STABLE COMPOSITIONS OF FACTOR IX

IPC classification:
A61K 38/36, C12N 9/64
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13189447

Immobilized biologically active entities having a high degree of biological activity

IPC classification:
A61K 31/727, A61K 38/17, A61L 2/00, A61L 27/20, A61L 27/34, A61L 27/54, A61L 31/10, A61L 31/12, A61L 33/00, A61L 33/06, A61L 33/08
Applicant:
W.L. Gore & Associates Inc
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14175887

Novel compound useful for the treatment of degenerative and inflammatory diseases

IPC classification:
A61K 31/437, A61P 29/00, A61P 35/00, A61P 37/00, C07D 471/04
Applicant:
Galapagos NV
Agent:
Andrew John Teuten, Sagittarius IP
Status:
PATENT GRANTED
EP12774625

STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR TREATMENT OF GRAM POSITIVE BACTERIA IN COMPANION ANIMALS AND LIVESTOCK

IPC classification:
A61K 38/47
Applicant:
Universiteit Utrecht Holding BV
Applicant:
The Rockefeller University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION WITHDRAWN
EP12869333

DETECTION OF SPECIFIC ANTIGENS IN A POPULATION OF ANTIGENS

IPC classification:
G01N 33/53, G01N 33/566, G01N 33/567
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP11803026

NON-INVASIVE MEASUREMENT OF BLOOD OXYGEN SATURATION

IPC classification:
A61B 5/00, A61B 5/026, A61B 5/145, A61B 5/1455
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP12762365

OPHTHALMIC FORMULATIONS

IPC classification:
A61K 9/00, A61K 9/08, A61K 9/12, A61K 31/79, A61K 33/18, A61K 47/38, A61P 31/00, A61P 31/04, A61P 31/10
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13757471

METHODS FOR MODULATION OF PHOSPHORUS AND FGF23

IPC classification:
A01N 59/16, A61K 38/21, A61K 39/00, A61K 51/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION WITHDRAWN
EP13758033

TGF- 1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF

IPC classification:
A61K 39/395, C07K 16/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13711104

NOVEL PHARMACEUTICAL FORMULATIONS

IPC classification:
A61K 9/00, A61K 47/12, A61K 47/26, C07D 487/04
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13711105

CRYSTALLINE PI3 KINASE INHIBITORS

IPC classification:
C07D 487/04
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
PATENT GRANTED
EP13778780

HUMAN ANTIBODIES AND SPECIFIC BINDING SEQUENCES THEREOF FOR USE IN STROKE AND ISCHEMIA OR ISCHEMIC CONDITIONS

IPC classification:
A61K 39/395
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Andrew John Teuten, Sagittarius IP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13787555

BIOFILM PREVENTION, DISRUPTION AND TREATMENT WITH BACTERIOPHAGE LYSIN

IPC classification:
A61K 38/00, A61K 39/085, C12N 9/52
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13800583

POWER DOOR OPENER

IPC classification:
B66F 19/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP13787128

BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA

IPC classification:
A61K 39/085, C12N 9/52
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13797721

TISSUE REPAIR DEVICES AND SCAFFOLDS

IPC classification:
A61F 2/02, A61F 2/28, A61L 27/54, A61L 27/56
Applicant:
New York University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION WITHDRAWN
EP13766525

CELL LINES

IPC classification:
C12N 15/67, C12P 21/02
Applicant:
MedImmune Limited
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13766526

AMINO ACID DERIVATIVES

IPC classification:
C07C 233/49, C07C 233/56, C07C 247/04, C07C 271/12, C07C 271/20, C07C 271/22, C12N 15/67, C12P 21/02
Applicant:
MedImmune Limited
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14787478

TREATMENT OF ALZHEIMER'S AND COGNITIVE IMPAIRMENT WITH ANDROGRAPHOLIDES

IPC classification:
A61K 31/365, A61K 36/19, A61P 25/28
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP12858356

DECELLULARIZED SMALL PARTICLE TISSUE

IPC classification:
A61K 38/39
Agent:
Andrew John Teuten, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP11787742

QUINAZOLIN-4(3H)-ONE DERIVATIVES USED AS PI3 KINASE INHIBITORS

IPC classification:
A61K 31/519, A61P 11/00, A61P 11/06, A61P 17/00, A61P 19/02, A61P 35/00, C07D 487/04
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10835594

CYSTEINE PROTEASE INHIBITORS

IPC classification:
A61K 31/16, A61K 31/415, A61K 31/426, A61P 9/10, A61P 11/06, A61P 17/06, A61P 21/04, A61P 37/02, A61P 37/08, C07C 271/22, C07D 231/40, C07D 277/46, C07D 405/12
Agent:
Multiple attorneys, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14717612

POROUS COMPOSITES WITH PACLITAXEL CRYSTALS

IPC classification:
A61K 31/337, A61L 27/34, A61L 29/14
Applicant:
W.L. Gore & Associates Inc
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP14714307

STABLE AQUEOUS FORMULATIONS OF ADENOVIRUS VECTORS

IPC classification:
A61K 9/00, A61K 47/36, A61K 48/00, C12N 15/86
Agent:
Andrew John Teuten, Sagittarius IP
Status:
The patent has been granted
EP14721092

COATING FOR A SURFACE

IPC classification:
A61L 27/34, A61L 29/08, A61L 31/10
Applicant:
W.L. Gore & Associates Inc
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14712334

2-((4-AMINO-3-(3-FLUORO-5-HYDROXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1 -YL)METHYL)-3-(2-(TRIFLUOROMET HYL)BENZYL)QUINAZOLIN-4(3H)-ONE DERIVATIVES AND THEIR USE AS PHOSPHOINOSITIDE 3-KINASE INHIBITORS

IPC classification:
A61K 31/519, A61P 11/00, A61P 17/00, A61P 19/00, A61P 31/12, A61P 35/00, C07D 487/04
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
The patent has been granted
EP15188438

AMIDO COMPOUNDS AS RORYT MODULATORS AND USES THEREOF

IPC classification:
A61K 31/12, A61K 31/33, A61K 31/4453, A61K 31/4525, A61K 31/535, C07C 235/34, C07C 235/36, C07D 317/54, C07D 317/60, C07D 401/10, C07D 403/14, C07D 405/06
Applicant:
New York University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11753726

AMIDO COMPOUNDS AS RORyt MODULATORS AND USES THEREOF

IPC classification:
A61K 31/4025, A61K 31/404, A61K 31/4453, A61K 31/4525, A61K 31/453, A61K 31/495, A61K 31/496, A61K 31/535, A61K 31/5375, A61P 29/00, A61P 37/00, C07C 235/34, C07C 235/36, C07D 211/16, C07D 307/52, C07D 317/54, C07D 317/60, C07D 403/14, C07D 405/06
Applicant:
New York University
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11810417

COMBINATION THERAPY WITH MDM2 AND EFGR INHIBITORS

IPC classification:
A61K 31/4709, A61K 31/517, A61K 45/06, A61P 35/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11713510

PYRAZOLE P38 MAP KINASE INHIBITORS

IPC classification:
A61K 31/4439, A61K 31/506, A61P 11/06, A61P 17/00, A61P 17/06, A61P 29/00, A61P 35/00, C07D 401/12, C07D 401/14, C07D 403/12
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11728920

UREIDO-PYRAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF RHINOVIRUS INFECTIONS

IPC classification:
A61K 31/415, A61K 31/4439, A61K 31/496, A61K 31/5377, A61P 11/00, A61P 11/06, A61P 31/00, A61P 31/16, C07D 401/12, C07D 401/14, C07D 403/12, C07D 405/14, C07D 413/14
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11779842

NOVEL COMPOSITION COMPRISING GLUCAGON

IPC classification:
A61K 38/26
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14851038

AMINO, AMIDO, AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF

IPC classification:
A61P 25/28
Applicant:
New York University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP11795278

NEW CATHEPSIN S PROTEASE INHIBITORS, USEFUL IN THE TREATMENT OF E.G. AUTOIMMUNE DISORDERS, ALLERGY AND CHRONIC PAIN CONDITIONS

IPC classification:
A61K 31/16, A61P 11/00, A61P 37/00, C07C 237/14, C07D 233/58
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11738789

STABILIZED AQUEOUS ANTIBODY COMPOSITIONS

IPC classification:
A61K 39/00, A61K 39/395, A61K 47/34, C07K 16/00, C07K 16/22, C07K 16/28, C07K 16/32
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12859754

COMBINATION THERAPY WITH INTERFERON BETA AND ANDROGRAPHOLIDES FOR MULTIPLE SCLEROSIS

IPC classification:
A61K 31/341, A61K 38/21, A61P 25/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14805880

IONIC AQUEOUS COMPOSITIONS

IPC classification:
A61K 35/74, A61K 36/03, A61K 36/04, A61K 36/53, A61P 11/00, A61P 31/00, A61P 31/16
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP16172826

METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON

IPC classification:
A61K 31/715, A61P 7/06
Agent:
Andrew John Teuten, Sagittarius IP
Agent:
Gille Habral
Status:
EXAMINATION REQUESTED
EP14862298

EPHEDRA ALATA EXTRACTS AND METHODS OF USE THEREOF

IPC classification:
A61K 36/17
Agent:
Andrew John Teuten, Sagittarius IP
Status:
APPLICATION WITHDRAWN
EP11704308

SANGLIFEHRIN BASED COMPOUNDS

IPC classification:
A61K 31/5025
Agent:
Andrew John Teuten, Sagittarius IP
Agent:
Marianne Johansen, Chas. Hude AS
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11708188

NUTRACEUTICAL CHOCOLATE OR COMPOUND CHOCOLATE PRODUCT

IPC classification:
A23G 1/42, A23G 1/54, A61K 9/00, A61P 27/02, A61P 39/06
Agent:
Andrew John Teuten, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15740526

WRAP AROUND BED FRAME

IPC classification:
A47C 19/02
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15746159

PROGRANULIN (PGRN) AND ITS DERIVATIVES FOR DIAGNOSIS AND TREATMENT OF LYSOSOMAL STORAGE DISEASES

IPC classification:
A61P 3/00
Applicant:
New York University
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15705797

AROMATIC HETEROCYCLIC COMPOUNDS AS ANTIINFLAMMATORY COMPOUNDS

IPC classification:
A61K 31/497, A61P 29/00, A61P 37/00, C07D 401/14
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15706511

PYRAZOLYL-UREAS AS KINASE INHIBITORS

IPC classification:
A61K 31/506, A61P 11/00, A61P 29/00, A61P 31/00, C07D 401/14, C07D 409/14
Applicant:
Respivert Ltd
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15796715

THREE DIMENSIONAL CONNECTION SYSTEM FOR BED FRAME

IPC classification:
A47C 19/02
Agent:
Andrew John Teuten, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15845303

SEEDING AN ADHERENT CELL BIOREACTOR WITH NON-ADHERENT CELLS INCREASES SEEDING DENSITY LIMIT AND REDUCES REQUIRED EXPANSION TIME

IPC classification:
C12N 5/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made
EP15843649

NOVEL IMIDAZOPYRIDAZINE COMPOUNDS AND THEIR USE

IPC classification:
A61K 31/5025, A61K 31/505, A61K 31/519, A61K 31/52, A61P 11/00, A61P 19/02, A61P 29/00, A61P 35/00, A61P 37/00, C07D 487/04, C07D 519/00
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made
EP15784440

NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVE

IPC classification:
A61K 31/55, A61P 31/14, C07D 495/04
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made
EP15782045

NOVEL 5,6-DIHYDRO-4H-BENZO[B]THIENO-[2,3-D]AZEPINE DERIVATIVES

IPC classification:
A61K 31/55, A61P 31/14, C07D 495/04
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made
EP15808770

ANTIMYCOTIC COMPOUND

IPC classification:
A61P 31/10, C07D 405/06
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made
EP15817507

ANTIMYCOTIC COMPOUND

IPC classification:
A61P 31/10, C07D 405/06
Agent:
Andrew John Teuten, Sagittarius IP
Status:
Request for examination was made

Please Sign in to use this feature